Standout Papers
- Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial (2013)
- Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial (2009)
Immediate Impact
2 by Nobel laureates 7 from Science/Nature 65 standout
Citing Papers
Theranostic Fluorescent Probes
2024 Standout
Fluorescent Probes for Disease Diagnosis
2024 Standout
Works of Eizo Kimura being referenced
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
2013 Standout
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Eizo Kimura | 735 | 381 | 121 | 363 | 20 | 1.1k | |
| M. Piccart | 668 | 416 | 111 | 469 | 21 | 1.1k | |
| C. Tropé | 874 | 449 | 129 | 370 | 11 | 1.1k | |
| W ten Bokkel Huinink | 543 | 411 | 146 | 448 | 22 | 1.2k | |
| S. Olbricht | 704 | 396 | 96 | 324 | 14 | 859 | |
| Anderley Gordon | 896 | 569 | 130 | 526 | 31 | 1.3k | |
| Ahmed Elattar | 689 | 391 | 106 | 448 | 32 | 1.1k | |
| Darren Wheeler | 554 | 281 | 162 | 253 | 30 | 1.1k | |
| N. Einhorn | 551 | 311 | 93 | 197 | 35 | 951 | |
| E. A. Eisenhauer | 483 | 296 | 246 | 397 | 30 | 1.1k | |
| Mindert Krans | 409 | 225 | 88 | 217 | 19 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...